BioSpace News Archive

Acerus Pharmaceuticals Corporation (“Acerus”) (TSX:ASP) today announced the voting results from its annual meeting of shareholders held on June 27, 2019 in Toronto, Ontario

Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced the pricing of its upsized initial public offering of 5,578,124 shares of common stock at a public offering price of $16.00 per share.

Positive outcome and two-year contract are the result of first negotiations between Brigham and MNA nurses since historic near strike in 2016

Fuse Medical, Inc., (OTCPK: FZMD), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the results of its 2019 Annual Shareholder Meeting that was held on Wednesday, June 26, 2019.

Awareness of Risks with Prescription Pain Medications is Key to Addressing Epidemic

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that the U.S. Food and Drug Administration (FDA) approved SOLIRIS® (eculizumab) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today a new Peptide Drug Conjugate “PDC” collaboration agreement with Swiss-based Novartis (“Novartis”)

CryoTherapeutics GmbH and CryoTherapeutics SA today announced the closing of its B round of financing.

MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today the launch of Automatiqc™ (pronounced: automatic

BioNJ, New Jersey’s life sciences trade association, today unveiled its new “Protecting Medical Innovation: Ensuring Patient Access to Cures” web portal at www.BioNJ.org/Protect-Medical-Innovation, launched in concert with a full digital marketing campaign.